TR200100070A3 - Bilesim - Google Patents

Bilesim

Info

Publication number
TR200100070A3
TR200100070A3 TR2001/00070A TR200100070A TR200100070A3 TR 200100070 A3 TR200100070 A3 TR 200100070A3 TR 2001/00070 A TR2001/00070 A TR 2001/00070A TR 200100070 A TR200100070 A TR 200100070A TR 200100070 A3 TR200100070 A3 TR 200100070A3
Authority
TR
Turkey
Prior art keywords
compound
Prior art date
Application number
TR2001/00070A
Other languages
English (en)
Other versions
TR200100070A2 (tr
Inventor
Victor Lloyd Potter Barry
John Reed Michael
Elger Walter
Roddersen Gudrun
Proske Heinrich-Thomas
Original Assignee
Sterix Limited
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0000792A external-priority patent/GB0000792D0/en
Priority claimed from GB0002115A external-priority patent/GB0002115D0/en
Application filed by Sterix Limited, Schering Aktiengesellschaft filed Critical Sterix Limited
Publication of TR200100070A3 publication Critical patent/TR200100070A3/tr
Publication of TR200100070A2 publication Critical patent/TR200100070A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Confectionery (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
TR2001/00070A 2000-01-14 2001-01-11 Bileşim TR200100070A2 (tr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0000792A GB0000792D0 (en) 2000-01-14 2000-01-14 Composition
GB0002115A GB0002115D0 (en) 2000-01-28 2000-01-28 Composition
US21873000P 2000-07-17 2000-07-17

Publications (2)

Publication Number Publication Date
TR200100070A3 true TR200100070A3 (tr) 2001-08-21
TR200100070A2 TR200100070A2 (tr) 2001-08-21

Family

ID=27255470

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00070A TR200100070A2 (tr) 2000-01-14 2001-01-11 Bileşim

Country Status (26)

Country Link
EP (1) EP1248626B1 (tr)
JP (1) JP2003519658A (tr)
KR (1) KR20020087930A (tr)
CN (1) CN1404394A (tr)
AR (1) AR028196A1 (tr)
AT (1) ATE332140T1 (tr)
AU (1) AU2533101A (tr)
BG (1) BG106914A (tr)
BR (1) BR0107630A (tr)
CA (1) CA2396098A1 (tr)
CO (1) CO5280199A1 (tr)
CZ (1) CZ20022282A3 (tr)
DE (1) DE60121293T2 (tr)
EE (1) EE200200391A (tr)
ES (1) ES2267707T3 (tr)
HR (1) HRP20020665A2 (tr)
HU (1) HUP0300887A2 (tr)
IL (1) IL150471A0 (tr)
MX (1) MXPA01000464A (tr)
NO (1) NO20023392L (tr)
PE (1) PE20011121A1 (tr)
PL (1) PL357020A1 (tr)
SK (1) SK10022002A3 (tr)
TR (1) TR200100070A2 (tr)
UY (1) UY26530A1 (tr)
WO (1) WO2001051055A2 (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (de) 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
GB0020498D0 (en) 2000-08-18 2000-10-11 Sterix Ltd Compound
GB0025788D0 (en) * 2000-10-20 2000-12-06 Sterix Ltd Use
EP1358882A1 (en) * 2002-04-30 2003-11-05 Schering Aktiengesellschaft Use of estriol sulfamate prodrugs for the treatment of autoimmune diseases
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
KR200449618Y1 (ko) * 2008-01-16 2010-07-23 주식회사 코비스 스포츠 그린보수기
GB201302368D0 (en) * 2013-02-11 2013-03-27 Univ Bath Compound
EP4098264A1 (en) * 2017-06-01 2022-12-07 Nexyon Biotech Co., Ltd. Pharmaceutical composition for prevention or treatment of bone-related disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556847A (en) * 1994-10-27 1996-09-17 Duquesne University Of The Holy Ghost Methods of effecting memory enhancement mediated by steroid sulfatase inhibitors
US5891868A (en) * 1997-11-21 1999-04-06 Kaiser Foundation Health Plan, Inc. Methods for treating postmenopausal women using ultra-low doses of estrogen

Also Published As

Publication number Publication date
DE60121293D1 (de) 2006-08-17
WO2001051055A2 (en) 2001-07-19
CO5280199A1 (es) 2003-05-30
IL150471A0 (en) 2002-12-01
EE200200391A (et) 2003-12-15
PL357020A1 (en) 2004-07-12
DE60121293T2 (de) 2007-06-28
SK10022002A3 (sk) 2002-12-03
UY26530A1 (es) 2001-07-31
CA2396098A1 (en) 2001-07-19
BR0107630A (pt) 2002-10-08
JP2003519658A (ja) 2003-06-24
BG106914A (en) 2003-01-31
MXPA01000464A (es) 2003-07-21
EP1248626B1 (en) 2006-07-05
EP1248626A2 (en) 2002-10-16
AR028196A1 (es) 2003-04-30
CZ20022282A3 (cs) 2002-11-13
ES2267707T3 (es) 2007-03-16
HRP20020665A2 (en) 2004-12-31
ATE332140T1 (de) 2006-07-15
CN1404394A (zh) 2003-03-19
KR20020087930A (ko) 2002-11-23
AU2533101A (en) 2001-07-24
NO20023392L (no) 2002-09-16
TR200100070A2 (tr) 2001-08-21
HUP0300887A2 (hu) 2003-07-28
PE20011121A1 (es) 2001-11-05
WO2001051055A3 (en) 2002-03-21
NO20023392D0 (no) 2002-07-12

Similar Documents

Publication Publication Date Title
NO20026196L (no) Kinazolinditosylatsalt-forbindelser
DK1619192T3 (da) Arylkondeserede azapolycykliske forbindelser
DK1226127T3 (da) Substituerede phenylsulfamoylcarboxamider
DK1255740T3 (da) Substituerede arylpyraziner
AR028393A1 (es) Iminoazidas substituidas
AR027983A1 (es) Novedosos compuestos
AR028302A1 (es) Feniluracilos substituidos
ID29755A (id) Senyawa-senyawa organosilikon
PT1299356E (pt) Novos compostos
DE50112662D1 (de) Substituierte benzoylcyclohexenone
ATE372338T1 (de) Deshalogenverbindungen
AR028220A1 (es) Novedosos compuestos
NO20023508L (no) Kalsilyttiske forbindelser
NO20031837D0 (no) Kalsilytiske forbindelser
NO20030303L (no) Kalsilytiske forbindelser
TR200100070A3 (tr) Bilesim
AR028399A1 (es) Nuevos compuestos
SE0004680D0 (sv) New compound
SE0003477D0 (sv) Compounds
SE0001804D0 (sv) New compounds II
IS8579A (is) Ný efnasambönd
SE0003640D0 (sv) New compounds
AR027949A1 (es) Novedosos compuestos
SE0000263D0 (sv) New compounds
SE0002788D0 (sv) New compounds